A detailed history of Chartwell Investment Partners, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Chartwell Investment Partners, LLC holds 35,800 shares of LNTH stock, worth $3.49 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
35,800
Previous 22,543 58.81%
Holding current value
$3.49 Million
Previous $1.81 Million 117.07%
% of portfolio
0.13%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$77.7 - $123.62 $1.03 Million - $1.64 Million
13,257 Added 58.81%
35,800 $3.93 Million
Q2 2024

Aug 08, 2024

SELL
$58.87 - $83.05 $215,640 - $304,212
-3,663 Reduced 13.98%
22,543 $1.81 Million
Q1 2024

May 14, 2024

BUY
$51.07 - $68.26 $31,663 - $42,321
620 Added 2.42%
26,206 $1.63 Million
Q4 2023

Feb 15, 2024

SELL
$55.6 - $77.89 $191,986 - $268,954
-3,453 Reduced 11.89%
25,586 $1.59 Million
Q2 2023

Jul 25, 2023

BUY
$82.41 - $99.65 $115,868 - $140,107
1,406 Added 5.09%
29,039 $2.44 Million
Q1 2023

Apr 14, 2023

BUY
$47.76 - $82.86 $500,238 - $867,875
10,474 Added 61.04%
27,633 $2.28 Million
Q4 2022

Feb 15, 2023

BUY
$48.76 - $77.67 $47,736 - $76,038
979 Added 6.05%
17,159 $875,000
Q3 2022

Oct 27, 2022

SELL
$61.42 - $86.29 $144,889 - $203,558
-2,359 Reduced 12.72%
16,180 $1.14 Million
Q2 2022

Aug 01, 2022

BUY
$55.54 - $72.65 $1.03 Million - $1.35 Million
18,539 New
18,539 $1.22 Million
Q2 2018

Aug 09, 2018

SELL
$13.65 - $18.7 $1.07 Million - $1.46 Million
-78,123 Closed
0 $0
Q1 2018

May 08, 2018

SELL
$14.85 - $24.3 $1.25 Million - $2.05 Million
-84,422 Reduced 51.94%
78,123 $1.6 Million
Q1 2018

May 08, 2018

BUY
$14.85 - $24.3 $1.25 Million - $2.05 Million
84,422 Added 108.06%
162,545 $2.58 Million
Q4 2017

Feb 08, 2018

BUY
$17.4 - $23.4 $1.36 Million - $1.83 Million
78,123
78,123 $1.6 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.7B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.